182 related articles for article (PubMed ID: 11427857)
21. The role of bullous pemphigoid antibodies in dermal-epidermal separation.
Haustein UF
J Invest Dermatol; 1989 Jan; 92(1):133. PubMed ID: 2642509
[No Abstract] [Full Text] [Related]
22. Bullous pemphigoid of childhood: immunofluorescent investigation.
Tamaki K; Igarashi A; Nakamura K; Nashiro K; Okochi H; Seki Y; Tsuchida T
J Dermatol; 1988 Oct; 15(5):400-4. PubMed ID: 3065382
[No Abstract] [Full Text] [Related]
23. Bullous pemphigoid antibodies.
Accetta PJ; Tarfare N; Helm F; Beutner EH
Arch Dermatol; 1986 May; 122(5):505. PubMed ID: 3085598
[No Abstract] [Full Text] [Related]
24. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180 kDa bullous pemphigoid antigen.
Hashimoto T; Han-Yaku H; Higashiyama M; Hashimoto K; Iwatsuki K; Kaneko F; Murakami H; Nishikawa T
Br J Dermatol; 1997 Aug; 137(2):305-6. PubMed ID: 9292089
[No Abstract] [Full Text] [Related]
25. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain.
Lin MS; Fu CL; Giudice GJ; Olague-Marchan M; Lazaro AM; Stastny P; Diaz LA
J Invest Dermatol; 2000 Dec; 115(6):955-61. PubMed ID: 11121125
[TBL] [Abstract][Full Text] [Related]
26. [Pemphigoid gestationis without blisters].
Ogilvie P; Trautmann A; Dummer W; Rose C; Bröcker EB; Zillikens D
Hautarzt; 2000 Jan; 51(1):25-30. PubMed ID: 10663036
[TBL] [Abstract][Full Text] [Related]
27. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
28. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
[TBL] [Abstract][Full Text] [Related]
29. Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts.
Bowszyc-Dmochowska M; Dmochowski M
J Med; 2002; 33(1-4):189-98. PubMed ID: 12939118
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
[TBL] [Abstract][Full Text] [Related]
31. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.
Patsatsi A; Vyzantiadis TA; Devliotou-Panagiotidou D; Chrysomallis F; Sotiriadis D
Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242
[TBL] [Abstract][Full Text] [Related]
32. Association of KM genotype with bullous pemphigoid.
Raux G; Gilbert D; Joly P; Daveau M; Martel P; Christ M; Tron F
J Autoimmun; 2000 Feb; 14(1):79-82. PubMed ID: 10648118
[TBL] [Abstract][Full Text] [Related]
33. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
[No Abstract] [Full Text] [Related]
34. Rat bladder epithelium: a sensitive substrate for indirect immunofluorescence of bullous pemphigoid.
Delmonte S; Cozzani E; Drosera M; Parodi A; Rebora A
Acta Derm Venereol; 2000 May; 80(3):175-8. PubMed ID: 10954206
[TBL] [Abstract][Full Text] [Related]
35. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
Hara H; Makino T; Matsui K; Takegami Y; Koga H; Fukuda S; Ishii N; Hashimoto T; Shimizu T
Eur J Dermatol; 2014; 24(4):488-9. PubMed ID: 25178966
[No Abstract] [Full Text] [Related]
36. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
[TBL] [Abstract][Full Text] [Related]
37. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
38. Blistering insights into the pathogenesis of bullous pemphigoid.
Wong HK; Bechtel MA
Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
[No Abstract] [Full Text] [Related]
39. The immunopathology of bullous pemphigoid.
Imber MJ; Murphy GF; Jordon RE
Clin Dermatol; 1987; 5(1):81-92. PubMed ID: 3552196
[No Abstract] [Full Text] [Related]
40. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
Chan LS
Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
